← Leaderboards
Katherine A High
Children'S Hospital Of Philadelphia
$15,374,120
Attributed
$15,374,120
Total exposure
15
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$39,147,375 · 16
By mechanism
P01$32,062,663 · 9
T32$2,743,968 · 1
G20$1,967,936 · 1
U01$1,491,900 · 2
R01$590,826 · 1
P50$277,082 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Valder R Arruda$13,574,051
- Albert J. Wong$7,669,833
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyHemophilia BFundingBaseAdultInhibitor/AntagonistVectorMuscleAnimal ModelLaboratory MouseAdeno-Associated Viral VectorAreaResearch StudyCanis FamiliarisImmune ResponseFactor IxAntigensSerotypingTransfection /Expression VectorBiotechnologyDoseHemophilia AsCoagulation Factor IxGene Transfer
Grant awards (67)
Gene Therapy for Hemophilia Using Muscle-Expressed FVIIa$450,208
P01 · FY2015 · HL · contact PI
Administrative Core for Gene Therapy of Hemophilia$178,354
P01 · FY2015 · HL · contact PI
Gene Therapy for Hemophilia$1,963,829
P01 · FY2013 · HL · contact PI
Gene Therapy for Hemophilia Using Muscle-Expressed FVIIa$430,683
P01 · FY2013 · HL · contact PI
Immune Responses to Capsid in AAV-Mediated Gene Transfer$353,232
P01 · FY2013 · HL · contact PI
Pediatric Hematology Research Training Program$263,387
T32 · FY2013 · HL · contact PI
Administrative Core for Gene Therapy of Hemophilia$171,797
P01 · FY2013 · HL · contact PI
Gene Therapy for Hemophilia$2,069,413
P01 · FY2012 · HL · contact PI
Gene Therapy for Hemophilia Using Muscle-Expressed FVIIa$450,426
P01 · FY2012 · HL · contact PI
Immune Responses to Capsid in AAV-Mediated Gene Transfer$371,041
P01 · FY2012 · HL · contact PI
Administrative Core for Gene Therapy of Hemophilia$178,450
P01 · FY2012 · HL · contact PI
Pediatric Hematology Research Training Program$117,138
T32 · FY2012 · HL · contact PI
Gene Therapy for Hemophilia$1,951,418
P01 · FY2011 · HL · contact PI
Gene Therapy for Hemophilia Using Muscle-Expressed FVIIa$371,508
P01 · FY2011 · HL · contact PI
Immune Responses to Capsid in AAV-Mediated Gene Transfer$371,041
P01 · FY2011 · HL · contact PI
Pediatric Hematology Research Training Program$263,059
T32 · FY2011 · HL · contact PI
Administrative Core for Gene Therapy of Hemophilia$99,494
P01 · FY2011 · HL · contact PI
Pathway to Accelerate Clinical Development in Gene Transfer: cGMP Vector Core$1,967,936
G20 · FY2010 · RR · contact PI
Immune Responses to Capsid in AAV-Mediated Gene Transfer$388,391
P01 · FY2010 · HL · contact PI
Pediatric Hematology Research Training Program$258,834
T32 · FY2010 · HL · contact PI
Clinical Trials Training Symposium$13,000
R13 · FY2010 · HL · contact PI
Gene Therapy for Hemophilia$1,915,518
P01 · FY2009 · HL · contact PI
Safety & Efficacy of Intravas. Del. of AAV-F.IX to Skeletal Muscle$367,300
P01 · FY2009 · HL · contact PI
Pediatric Hematology Research Training Program$256,735
T32 · FY2009 · HL · contact PI
Gene Therapy for Hemophilia$1,828,821
P01 · FY2008 · HL · contact PI
Safety & Efficacy of Intravas. Del. of AAV-F.IX to Skeletal Muscle$349,395
P01 · FY2008 · HL · contact PI
Pediatric Hematology Research Training Program$254,661
T32 · FY2008 · HL · contact PI
Gene Therapy for Hemophilia$1,857,933
P01 · FY2007 · HL · contact PI
Biological Roles of Factors X and Xa$407,264
P01 · FY2007 · HL · contact PI
Safety & Efficacy of Intravas. Del. of AAV-F.IX to Skeletal Muscle$345,664
P01 · FY2007 · HL · contact PI
Pediatric Hematology Research Training Program$254,661
T32 · FY2007 · HL · contact PI
Gene Therapy for Hemophilia$1,862,808
P01 · FY2006 · HL · contact PI
Biological Roles of Factors X and Xa$420,578
P01 · FY2006 · HL · contact PI
Safety & Efficacy of Intravas. Del. of AAV-F.IX to Skeletal Muscle$331,892
P01 · FY2006 · HL · contact PI
Pediatric Hematology Research Training Program$121,048
T32 · FY2006 · HL · contact PI
Gene Therapy for Hemophilia$1,851,870
P01 · FY2005 · HL
Biological Roles of Factors X and Xa$408,330
P01 · FY2005 · HL
Safety &Efficacy of Intravas. Del. of AAV-F.IX to Skeletal Muscle$322,226
P01 · FY2005 · HL
Administrative Core$112,759
P01 · FY2005 · HL
Pediatric Hematology Research Training Program$84,930
T32 · FY2005 · HL
GENE THERAPY FOR HEMOPHILIA$1,464,576
P01 · FY2004 · HL
AAV mediated muscle directed gene therapy for Hemophilia B$482,240
P01 · FY2004 · HL
Biological Roles of Factors X and Xa$396,437
P01 · FY2004 · HL
Pediatric Hematology Research Training Program$234,822
T32 · FY2004 · HL
Core A- Administrative Core$124,209
P01 · FY2004 · HL
GENE THERAPY FOR HEMOPHILIA$1,522,334
P01 · FY2003 · HL
Pediatric Hematology Research Training Program$231,448
T32 · FY2003 · HL
GENE THERAPY FOR HEMOPHILIA$1,579,875
P01 · FY2002 · HL
Gene based approach to treating hemophilic inhibitors$248,650
U01 · FY2002 · HL
Core--Training$248,650
U01 · FY2002 · HL
Pediatric Hematology Research Training Program$222,791
T32 · FY2002 · HL
AAV mediated muscle directed gene therapy for Hemophilia B$0
P01 · FY2002 · HL
GENE THERAPY FOR HEMOPHILIA$1,863,373
P01 · FY2001 · HL
AAV mediated muscle directed gene therapy for Hemophilia B$380,508
P01 · FY2001 · HL
INHIBITOR FORMATION IN GENE THERAPY FOR HEMOPHILIA$295,413
R01 · FY2001 · HL
Gene based approach to treating hemophilic inhibitors$248,650
U01 · FY2001 · HL
Core--Training$248,650
U01 · FY2001 · HL
PEDIATRIC HEMATOLOGY RESEARCH TRAINING PROGRAM$86,555
T32 · FY2001 · HL
GENE THERAPY FOR HEMOPHILIA$82,212
P01 · FY2001 · HL
AAV mediated muscle directed gene therapy for Hemophilia B$0
P01 · FY2001 · HL
GENE THERAPY FOR HEMOPHILIA$1,959,275
P01 · FY2000 · HL
INHIBITOR FORMATION IN GENE THERAPY FOR HEMOPHILIA$295,413
R01 · FY2000 · HL
GENE THERAPY OF HEMOPHILIA B USING HEMATOPOIETIC STEM CELLS$277,082
P50 · FY2000 · HL
Core--Training$248,650
U01 · FY2000 · HL
Gene based approach to treating hemophilic inhibitors$248,650
U01 · FY2000 · HL
PEDIATRIC HEMATOLOGY RESEARCH TRAINING PROGRAM$93,899
T32 · FY2000 · HL
AAV mediated muscle directed gene therapy for Hemophilia B$25,981
P01 · FY2000 · HL